A simulated maximum likelihood procedure for analyzing imprecise trade‐off thresholds between the benefits and harms of medicines
Sign Up to like & getrecommendations! Published in 2022 at "Statistics in Medicine"
DOI: 10.1002/sim.9583
Abstract: Stated preference studies in which information on the willingness to trade‐off between the benefits and harms of medicines is elicited from patients or other stakeholders are becoming increasingly mainstream. Such trade‐offs can mathematically be represented… read more here.
Keywords: harms medicines; procedure; benefits harms; trade ... See more keywords
Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Clinical Pharmacology"
DOI: 10.1007/s00228-017-2378-0
Abstract: Consideration of drug benefits and harms is asymmetric. Approval of drugs is mainly based on efficacy, while the assessment of their safety is left to post-marketing commitments or spontaneous reporting. Benefits are overestimated as a… read more here.
Keywords: overlooking harms; benefits risk; risk stop; benefits benefits ... See more keywords